Abstract
Patients with stable asthma can tolerate antihistamines without any significant deleterious effects both on a short- and a long-term basis. In addition, patients with steroid-dependent asthma appear to tolerate antihistamines without any significant deleterious effects. Therefore, oral chlorpheniramine does not appear to have ill effects on patients with asthma. Warning labels required by the FDA for antihistamine use in asthmatics are unnecessary.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
